Skip to main content
Bajaj Finserv Mutual Fund logo

Bajaj Finserv Healthcare Fund

Bajaj Finserv Mutual FundDirectOpen-endedSectoral/ ThematicRiskometer: Very High Risk

NAV

12.04

as of 21 Aug 2026

Bajaj Finserv Healthcare Fund is an open-ended Sectoral/ Thematic scheme from Bajaj Finserv Mutual Fund managing ₹377 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹12.04 as of 21 Aug 2026. The expense ratio is 0.66% a year. Managed by Siddharth Chaudhary. This page is factual data only — it carries no rating and no recommendation.

Key facts

Expense ratio
0.66% / yr
as of 30 Jun 2026
Fund size
₹377 crore
as of 31 Jul 2026
Exit load
1%
SIP available
Yes
Launched
27 Dec 2024
ISIN
INF0QA701AB9

₹100 invested, fund vs category

The category line is the average of the funds in this category, built from NYVO’s own NAV data.

Rebased to 100data to 20 Aug 2026Benchmark: Nifty 500 Healthcare TRI

Dec 2024Aug 2026
Growth of ₹100, Bajaj Finserv Healthcare Fund versus Sectoral/ Thematic average.

Bajaj Finserv Healthcare Fund

₹121

+21% on ₹100 over 1.6 yrs

Sectoral/ Thematic average

₹115

+15% on ₹100 over 1.6 yrs

Returns vs category

WindowFundCategory avgGap
3 months14.09%
6 months25.26%
1 year21.72%

No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.

Distance below its own peak

Every dip below 0 is the fund trading under a previous high — how deep and for how long is what a drawdown feels like.

Right now

-0.0% below peak

Dec 2024Deepest: -15.5%Aug 2026

Where the money actually is

Equity

96.6%

Bonds

0.2%

Cash

3.2%

Other

0.0%

Whole-portfolio split, as of 31 Jul 2026.

What it owns

35 positions · top 10 = 61.9%

Market-cap mix

Large 30.5%Mid 25.0%Small 41.0%Other 3.4%

as of 31 Jul 2026

Holdings by sector

  • Healthcare(10 in top 10)88.6%
    • Divi's Laboratories Ltd9.67%
    • Sun Pharmaceuticals Industries Ltd8.87%
    • Piramal Pharma Ltd6.60%
    • Apollo Hospitals Enterprise Ltd6.50%
    • Aurobindo Pharma Ltd6.13%
    • Rubicon Research Ltd6.01%
    • Torrent Pharmaceuticals Ltd5.48%
    • Neuland Laboratories Ltd4.42%
    • Emcure Pharmaceuticals Ltd4.37%
    • Max Healthcare Institute Ltd Ordinary Shares3.80%
  • Basic Materials4.3%
  • Consumer Defensive2.7%
  • Financial Services0.8%
  • Industrials0.2%

Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 3.6% a year.

The businesses it owns

P/E (trailing)
47.2
P/B
6.4
Dividend yield
0.4%
Net margin
13.7%
Earnings growth
17.9%
Avg market cap
₹62,528 crore

The debt it holds (debt sleeve)

Yield to maturity
6.67%
Modified duration
0.51 yrs
Average maturity
0.54 yrs
Government securities
0.2%

Credit quality

AAA
100.0%

Government securities are counted inside AAA by the data provider’s ladder; the sovereign share is listed separately above. Credit quality as of 30 Jun 2026.

Portfolio characteristics as of 31 Jul 2026. Yield to maturity is what the portfolio would return if every holding were held to maturity and paid in full. It is not a forecast of the fund’s return, and it is quoted before expenses.

Money in, money out

Net flow, 12 months
12 cr
Net flow, 3 months
+2 cr

as of 31 Jul 2026. Flows follow performance more than they predict it.

Quick answers

What is the NAV of Bajaj Finserv Healthcare Fund?
₹12.04 per unit as of 21 Aug 2026 (Direct plan, growth). NAV is declared daily on working days.
What is the expense ratio of Bajaj Finserv Healthcare Fund?
0.66% a year for the Direct plan, as of 30 Jun 2026.
How large is Bajaj Finserv Healthcare Fund?
₹377 crore under management as of 31 Jul 2026, in the Sectoral/ Thematic category.
How risky is Bajaj Finserv Healthcare Fund?
Its SEBI Riskometer reading is "Very High Risk". One sector, one story. The most-launched shelf on the map, by far.
Who manages Bajaj Finserv Healthcare Fund?
Siddharth Chaudhary, managing this fund for 1.6 years.

Where this fund sits

Other Sectoral/ Thematic funds

Data: NYVO research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty 500 Healthcare TRI) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.